The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Veterinary Pain Management Drugs Market Research Report 2025
Synopsis
Non-steroidal anti-inflammatory drugs are one of the most commonly used and most effective drug in the treatment of pain due to arthritis or after surgery in dogs and cats. Rimadyl®, Metacam®, Dermaxx®, and Etogesic® all belong to this class of drugs.
The global Veterinary Pain Management Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 142%.
This report aims to provide a comprehensive presentation of the global market for Veterinary Pain Management Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Pain Management Drugs.
Report Scope
The Veterinary Pain Management Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Veterinary Pain Management Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Pain Management Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Zoetis
Elanco (Bayer Animal Health)
Merck Animal Health
Virbac
Dechra Veterinary Products
Ceva Sante Animale
Vetoquinol
Meiji
Ourofino Saude Animal
Animalcare Group
Parnell
Segment by Type
Opioids
α2-Adrenergic Agonists
Local Anesthetics
Nonsteroidal Anti-Inflammatory Drugs (NSIDs)
Sedatives
Corticosteroids
Others
Segment by Application
Veterinary Hospitals
Veterinary Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Veterinary Pain Management Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Non-steroidal anti-inflammatory drugs are one of the most commonly used and most effective drug in the treatment of pain due to arthritis or after surgery in dogs and cats. Rimadyl®, Metacam®, Dermaxx®, and Etogesic® all belong to this class of drugs.
The global Veterinary Pain Management Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 142%.
This report aims to provide a comprehensive presentation of the global market for Veterinary Pain Management Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Pain Management Drugs.
Report Scope
The Veterinary Pain Management Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Veterinary Pain Management Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Pain Management Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Zoetis
Elanco (Bayer Animal Health)
Merck Animal Health
Virbac
Dechra Veterinary Products
Ceva Sante Animale
Vetoquinol
Meiji
Ourofino Saude Animal
Animalcare Group
Parnell
Segment by Type
Opioids
α2-Adrenergic Agonists
Local Anesthetics
Nonsteroidal Anti-Inflammatory Drugs (NSIDs)
Sedatives
Corticosteroids
Others
Segment by Application
Veterinary Hospitals
Veterinary Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Veterinary Pain Management Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Veterinary Pain Management Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Opioids
1.2.3 α2-Adrenergic Agonists
1.2.4 Local Anesthetics
1.2.5 Nonsteroidal Anti-Inflammatory Drugs (NSIDs)
1.2.6 Sedatives
1.2.7 Corticosteroids
1.2.8 Others
1.3 Market by Application
1.3.1 Global Veterinary Pain Management Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Veterinary Hospitals
1.3.3 Veterinary Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Veterinary Pain Management Drugs Market Perspective (2019-2030)
2.2 Veterinary Pain Management Drugs Growth Trends by Region
2.2.1 Global Veterinary Pain Management Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Veterinary Pain Management Drugs Historic Market Size by Region (2019-2024)
2.2.3 Veterinary Pain Management Drugs Forecasted Market Size by Region (2025-2030)
2.3 Veterinary Pain Management Drugs Market Dynamics
2.3.1 Veterinary Pain Management Drugs Industry Trends
2.3.2 Veterinary Pain Management Drugs Market Drivers
2.3.3 Veterinary Pain Management Drugs Market Challenges
2.3.4 Veterinary Pain Management Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Veterinary Pain Management Drugs Players by Revenue
3.1.1 Global Top Veterinary Pain Management Drugs Players by Revenue (2019-2024)
3.1.2 Global Veterinary Pain Management Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Veterinary Pain Management Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Veterinary Pain Management Drugs Revenue
3.4 Global Veterinary Pain Management Drugs Market Concentration Ratio
3.4.1 Global Veterinary Pain Management Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Veterinary Pain Management Drugs Revenue in 2023
3.5 Veterinary Pain Management Drugs Key Players Head office and Area Served
3.6 Key Players Veterinary Pain Management Drugs Product Solution and Service
3.7 Date of Enter into Veterinary Pain Management Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Veterinary Pain Management Drugs Breakdown Data by Type
4.1 Global Veterinary Pain Management Drugs Historic Market Size by Type (2019-2024)
4.2 Global Veterinary Pain Management Drugs Forecasted Market Size by Type (2025-2030)
5 Veterinary Pain Management Drugs Breakdown Data by Application
5.1 Global Veterinary Pain Management Drugs Historic Market Size by Application (2019-2024)
5.2 Global Veterinary Pain Management Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Veterinary Pain Management Drugs Market Size (2019-2030)
6.2 North America Veterinary Pain Management Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Veterinary Pain Management Drugs Market Size by Country (2019-2024)
6.4 North America Veterinary Pain Management Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Veterinary Pain Management Drugs Market Size (2019-2030)
7.2 Europe Veterinary Pain Management Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Veterinary Pain Management Drugs Market Size by Country (2019-2024)
7.4 Europe Veterinary Pain Management Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Veterinary Pain Management Drugs Market Size (2019-2030)
8.2 Asia-Pacific Veterinary Pain Management Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Veterinary Pain Management Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Veterinary Pain Management Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Veterinary Pain Management Drugs Market Size (2019-2030)
9.2 Latin America Veterinary Pain Management Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Veterinary Pain Management Drugs Market Size by Country (2019-2024)
9.4 Latin America Veterinary Pain Management Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Veterinary Pain Management Drugs Market Size (2019-2030)
10.2 Middle East & Africa Veterinary Pain Management Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Veterinary Pain Management Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Veterinary Pain Management Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Detail
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Veterinary Pain Management Drugs Introduction
11.1.4 Boehringer Ingelheim Revenue in Veterinary Pain Management Drugs Business (2019-2024)
11.1.5 Boehringer Ingelheim Recent Development
11.2 Zoetis
11.2.1 Zoetis Company Detail
11.2.2 Zoetis Business Overview
11.2.3 Zoetis Veterinary Pain Management Drugs Introduction
11.2.4 Zoetis Revenue in Veterinary Pain Management Drugs Business (2019-2024)
11.2.5 Zoetis Recent Development
11.3 Elanco (Bayer Animal Health)
11.3.1 Elanco (Bayer Animal Health) Company Detail
11.3.2 Elanco (Bayer Animal Health) Business Overview
11.3.3 Elanco (Bayer Animal Health) Veterinary Pain Management Drugs Introduction
11.3.4 Elanco (Bayer Animal Health) Revenue in Veterinary Pain Management Drugs Business (2019-2024)
11.3.5 Elanco (Bayer Animal Health) Recent Development
11.4 Merck Animal Health
11.4.1 Merck Animal Health Company Detail
11.4.2 Merck Animal Health Business Overview
11.4.3 Merck Animal Health Veterinary Pain Management Drugs Introduction
11.4.4 Merck Animal Health Revenue in Veterinary Pain Management Drugs Business (2019-2024)
11.4.5 Merck Animal Health Recent Development
11.5 Virbac
11.5.1 Virbac Company Detail
11.5.2 Virbac Business Overview
11.5.3 Virbac Veterinary Pain Management Drugs Introduction
11.5.4 Virbac Revenue in Veterinary Pain Management Drugs Business (2019-2024)
11.5.5 Virbac Recent Development
11.6 Dechra Veterinary Products
11.6.1 Dechra Veterinary Products Company Detail
11.6.2 Dechra Veterinary Products Business Overview
11.6.3 Dechra Veterinary Products Veterinary Pain Management Drugs Introduction
11.6.4 Dechra Veterinary Products Revenue in Veterinary Pain Management Drugs Business (2019-2024)
11.6.5 Dechra Veterinary Products Recent Development
11.7 Ceva Sante Animale
11.7.1 Ceva Sante Animale Company Detail
11.7.2 Ceva Sante Animale Business Overview
11.7.3 Ceva Sante Animale Veterinary Pain Management Drugs Introduction
11.7.4 Ceva Sante Animale Revenue in Veterinary Pain Management Drugs Business (2019-2024)
11.7.5 Ceva Sante Animale Recent Development
11.8 Vetoquinol
11.8.1 Vetoquinol Company Detail
11.8.2 Vetoquinol Business Overview
11.8.3 Vetoquinol Veterinary Pain Management Drugs Introduction
11.8.4 Vetoquinol Revenue in Veterinary Pain Management Drugs Business (2019-2024)
11.8.5 Vetoquinol Recent Development
11.9 Meiji
11.9.1 Meiji Company Detail
11.9.2 Meiji Business Overview
11.9.3 Meiji Veterinary Pain Management Drugs Introduction
11.9.4 Meiji Revenue in Veterinary Pain Management Drugs Business (2019-2024)
11.9.5 Meiji Recent Development
11.10 Ourofino Saude Animal
11.10.1 Ourofino Saude Animal Company Detail
11.10.2 Ourofino Saude Animal Business Overview
11.10.3 Ourofino Saude Animal Veterinary Pain Management Drugs Introduction
11.10.4 Ourofino Saude Animal Revenue in Veterinary Pain Management Drugs Business (2019-2024)
11.10.5 Ourofino Saude Animal Recent Development
11.11 Animalcare Group
11.11.1 Animalcare Group Company Detail
11.11.2 Animalcare Group Business Overview
11.11.3 Animalcare Group Veterinary Pain Management Drugs Introduction
11.11.4 Animalcare Group Revenue in Veterinary Pain Management Drugs Business (2019-2024)
11.11.5 Animalcare Group Recent Development
11.12 Parnell
11.12.1 Parnell Company Detail
11.12.2 Parnell Business Overview
11.12.3 Parnell Veterinary Pain Management Drugs Introduction
11.12.4 Parnell Revenue in Veterinary Pain Management Drugs Business (2019-2024)
11.12.5 Parnell Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Veterinary Pain Management Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Opioids
Table 3. Key Players of α2-Adrenergic Agonists
Table 4. Key Players of Local Anesthetics
Table 5. Key Players of Nonsteroidal Anti-Inflammatory Drugs (NSIDs)
Table 6. Key Players of Sedatives
Table 7. Key Players of Corticosteroids
Table 8. Key Players of Others
Table 9. Global Veterinary Pain Management Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Veterinary Pain Management Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global Veterinary Pain Management Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 12. Global Veterinary Pain Management Drugs Market Share by Region (2019-2024)
Table 13. Global Veterinary Pain Management Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 14. Global Veterinary Pain Management Drugs Market Share by Region (2025-2030)
Table 15. Veterinary Pain Management Drugs Market Trends
Table 16. Veterinary Pain Management Drugs Market Drivers
Table 17. Veterinary Pain Management Drugs Market Challenges
Table 18. Veterinary Pain Management Drugs Market Restraints
Table 19. Global Veterinary Pain Management Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 20. Global Veterinary Pain Management Drugs Market Share by Players (2019-2024)
Table 21. Global Top Veterinary Pain Management Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Pain Management Drugs as of 2023)
Table 22. Ranking of Global Top Veterinary Pain Management Drugs Companies by Revenue (US$ Million) in 2023
Table 23. Global 5 Largest Players Market Share by Veterinary Pain Management Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Veterinary Pain Management Drugs Product Solution and Service
Table 26. Date of Enter into Veterinary Pain Management Drugs Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Veterinary Pain Management Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 29. Global Veterinary Pain Management Drugs Revenue Market Share by Type (2019-2024)
Table 30. Global Veterinary Pain Management Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 31. Global Veterinary Pain Management Drugs Revenue Market Share by Type (2025-2030)
Table 32. Global Veterinary Pain Management Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 33. Global Veterinary Pain Management Drugs Revenue Market Share by Application (2019-2024)
Table 34. Global Veterinary Pain Management Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 35. Global Veterinary Pain Management Drugs Revenue Market Share by Application (2025-2030)
Table 36. North America Veterinary Pain Management Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Veterinary Pain Management Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Veterinary Pain Management Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Veterinary Pain Management Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Europe Veterinary Pain Management Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 41. Europe Veterinary Pain Management Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 42. Asia-Pacific Veterinary Pain Management Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 43. Asia-Pacific Veterinary Pain Management Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 44. Asia-Pacific Veterinary Pain Management Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 45. Latin America Veterinary Pain Management Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Latin America Veterinary Pain Management Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 47. Latin America Veterinary Pain Management Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 48. Middle East & Africa Veterinary Pain Management Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 49. Middle East & Africa Veterinary Pain Management Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 50. Middle East & Africa Veterinary Pain Management Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 51. Boehringer Ingelheim Company Detail
Table 52. Boehringer Ingelheim Business Overview
Table 53. Boehringer Ingelheim Veterinary Pain Management Drugs Product
Table 54. Boehringer Ingelheim Revenue in Veterinary Pain Management Drugs Business (2019-2024) & (US$ Million)
Table 55. Boehringer Ingelheim Recent Development
Table 56. Zoetis Company Detail
Table 57. Zoetis Business Overview
Table 58. Zoetis Veterinary Pain Management Drugs Product
Table 59. Zoetis Revenue in Veterinary Pain Management Drugs Business (2019-2024) & (US$ Million)
Table 60. Zoetis Recent Development
Table 61. Elanco (Bayer Animal Health) Company Detail
Table 62. Elanco (Bayer Animal Health) Business Overview
Table 63. Elanco (Bayer Animal Health) Veterinary Pain Management Drugs Product
Table 64. Elanco (Bayer Animal Health) Revenue in Veterinary Pain Management Drugs Business (2019-2024) & (US$ Million)
Table 65. Elanco (Bayer Animal Health) Recent Development
Table 66. Merck Animal Health Company Detail
Table 67. Merck Animal Health Business Overview
Table 68. Merck Animal Health Veterinary Pain Management Drugs Product
Table 69. Merck Animal Health Revenue in Veterinary Pain Management Drugs Business (2019-2024) & (US$ Million)
Table 70. Merck Animal Health Recent Development
Table 71. Virbac Company Detail
Table 72. Virbac Business Overview
Table 73. Virbac Veterinary Pain Management Drugs Product
Table 74. Virbac Revenue in Veterinary Pain Management Drugs Business (2019-2024) & (US$ Million)
Table 75. Virbac Recent Development
Table 76. Dechra Veterinary Products Company Detail
Table 77. Dechra Veterinary Products Business Overview
Table 78. Dechra Veterinary Products Veterinary Pain Management Drugs Product
Table 79. Dechra Veterinary Products Revenue in Veterinary Pain Management Drugs Business (2019-2024) & (US$ Million)
Table 80. Dechra Veterinary Products Recent Development
Table 81. Ceva Sante Animale Company Detail
Table 82. Ceva Sante Animale Business Overview
Table 83. Ceva Sante Animale Veterinary Pain Management Drugs Product
Table 84. Ceva Sante Animale Revenue in Veterinary Pain Management Drugs Business (2019-2024) & (US$ Million)
Table 85. Ceva Sante Animale Recent Development
Table 86. Vetoquinol Company Detail
Table 87. Vetoquinol Business Overview
Table 88. Vetoquinol Veterinary Pain Management Drugs Product
Table 89. Vetoquinol Revenue in Veterinary Pain Management Drugs Business (2019-2024) & (US$ Million)
Table 90. Vetoquinol Recent Development
Table 91. Meiji Company Detail
Table 92. Meiji Business Overview
Table 93. Meiji Veterinary Pain Management Drugs Product
Table 94. Meiji Revenue in Veterinary Pain Management Drugs Business (2019-2024) & (US$ Million)
Table 95. Meiji Recent Development
Table 96. Ourofino Saude Animal Company Detail
Table 97. Ourofino Saude Animal Business Overview
Table 98. Ourofino Saude Animal Veterinary Pain Management Drugs Product
Table 99. Ourofino Saude Animal Revenue in Veterinary Pain Management Drugs Business (2019-2024) & (US$ Million)
Table 100. Ourofino Saude Animal Recent Development
Table 101. Animalcare Group Company Detail
Table 102. Animalcare Group Business Overview
Table 103. Animalcare Group Veterinary Pain Management Drugs Product
Table 104. Animalcare Group Revenue in Veterinary Pain Management Drugs Business (2019-2024) & (US$ Million)
Table 105. Animalcare Group Recent Development
Table 106. Parnell Company Detail
Table 107. Parnell Business Overview
Table 108. Parnell Veterinary Pain Management Drugs Product
Table 109. Parnell Revenue in Veterinary Pain Management Drugs Business (2019-2024) & (US$ Million)
Table 110. Parnell Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Veterinary Pain Management Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Veterinary Pain Management Drugs Market Share by Type: 2023 VS 2030
Figure 3. Opioids Features
Figure 4. α2-Adrenergic Agonists Features
Figure 5. Local Anesthetics Features
Figure 6. Nonsteroidal Anti-Inflammatory Drugs (NSIDs) Features
Figure 7. Sedatives Features
Figure 8. Corticosteroids Features
Figure 9. Others Features
Figure 10. Global Veterinary Pain Management Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global Veterinary Pain Management Drugs Market Share by Application: 2023 VS 2030
Figure 12. Veterinary Hospitals Case Studies
Figure 13. Veterinary Clinics Case Studies
Figure 14. Others Case Studies
Figure 15. Veterinary Pain Management Drugs Report Years Considered
Figure 16. Global Veterinary Pain Management Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Veterinary Pain Management Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Veterinary Pain Management Drugs Market Share by Region: 2023 VS 2030
Figure 19. Global Veterinary Pain Management Drugs Market Share by Players in 2023
Figure 20. Global Top Veterinary Pain Management Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Pain Management Drugs as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Veterinary Pain Management Drugs Revenue in 2023
Figure 22. North America Veterinary Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Veterinary Pain Management Drugs Market Share by Country (2019-2030)
Figure 24. United States Veterinary Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Veterinary Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Veterinary Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Veterinary Pain Management Drugs Market Share by Country (2019-2030)
Figure 28. Germany Veterinary Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Veterinary Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Veterinary Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Veterinary Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Veterinary Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Veterinary Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Veterinary Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Veterinary Pain Management Drugs Market Share by Region (2019-2030)
Figure 36. China Veterinary Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Veterinary Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Veterinary Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Veterinary Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Veterinary Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Veterinary Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Veterinary Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Veterinary Pain Management Drugs Market Share by Country (2019-2030)
Figure 44. Mexico Veterinary Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Veterinary Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Veterinary Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Veterinary Pain Management Drugs Market Share by Country (2019-2030)
Figure 48. Turkey Veterinary Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Veterinary Pain Management Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Boehringer Ingelheim Revenue Growth Rate in Veterinary Pain Management Drugs Business (2019-2024)
Figure 51. Zoetis Revenue Growth Rate in Veterinary Pain Management Drugs Business (2019-2024)
Figure 52. Elanco (Bayer Animal Health) Revenue Growth Rate in Veterinary Pain Management Drugs Business (2019-2024)
Figure 53. Merck Animal Health Revenue Growth Rate in Veterinary Pain Management Drugs Business (2019-2024)
Figure 54. Virbac Revenue Growth Rate in Veterinary Pain Management Drugs Business (2019-2024)
Figure 55. Dechra Veterinary Products Revenue Growth Rate in Veterinary Pain Management Drugs Business (2019-2024)
Figure 56. Ceva Sante Animale Revenue Growth Rate in Veterinary Pain Management Drugs Business (2019-2024)
Figure 57. Vetoquinol Revenue Growth Rate in Veterinary Pain Management Drugs Business (2019-2024)
Figure 58. Meiji Revenue Growth Rate in Veterinary Pain Management Drugs Business (2019-2024)
Figure 59. Ourofino Saude Animal Revenue Growth Rate in Veterinary Pain Management Drugs Business (2019-2024)
Figure 60. Animalcare Group Revenue Growth Rate in Veterinary Pain Management Drugs Business (2019-2024)
Figure 61. Parnell Revenue Growth Rate in Veterinary Pain Management Drugs Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
